What Is Quoin Pharmaceuticals, Ltd. (QNRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Quoin Pharmaceuticals, Ltd. at its current price of $4.16. The composite intrinsic value is estimated at $4.06 (-2.4% average return), with 4 models flagging overvaluation risk. Model dispersion is worth noting: ML-RIV targets $11.57 (+178.2%), versus Sentiment SOTP at $0.09 (-97.8%). This +276.0% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About QNRX?
7 of 13 models are currently active for QNRX. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates QNRX's intrinsic value at $1.18, implying -71.7% downside from the current price. See which stocks rank higher →
How Does QNRX Rank in Pharmaceutical Preparations?
Among 438 Pharmaceutical Preparations stocks, QNRX ranks #423 by Quality of Company score. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Quoin Pharmaceuticals, Ltd. operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating QNRX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is QNRX a Value Trap?
CirclFi's Value Trap algorithm assigns QNRX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Quoin Pharmaceuticals, Ltd.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Quoin Pharmaceuticals, Ltd.'s fundamental quality profile registers 2.0/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +276.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every QNRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across QNRX's 7 active models, average confidence is 11%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad